Focus Stocks
Allergan near Key Resistance Area
Published on Wednesday, 08 September 2010 08:20 Written by Danny Miller
New York, September 8th (TradersHuddle.com) - Shares of Allergan Inc. ( NYSE:AGN) are trading very close to calculated resistance at $65.00 with the current price action closing at just $63.58 placing the stock near levels that make it difficult to buy.
Allergan, Inc. (NYSE:AGN) is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics and medical devices. The company develops products for the ophthalmic, neurological, medical aesthetics, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
Allergan's current stock range is defined by current calculated support defined at $59.52 and by the resistance level at $65.00, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Allergan, as the stock is well above support, however, as the stock pulls back towards $59.52 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $65.00 then traders will get an opportunity to enter Allergan stock by establishing a position as the stock moves to a higher range.
Related Partner Headlines
- UPDATE: Morgan Stanley Raises Allergan's PT - Benzinga
- Morgan Stanley Maintains Allergan at Overweight, Raises PT from $90 to $98 - Benzinga
- UPDATE: Deutsche Bank Lowers Target on Allergan to $95 - Benzinga
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- 7 Stocks Set to Rise Above $100 in 2012 - TheStreet.com
- Allergan Reaches New 52-Week High (AGN) - TheStreet.com
- 5 Unexpected Deals Themes for 2012 - TheStreet.com
- Allergan Inc. (AGN): Today's Featured Health Care Winner - TheStreet.com
- Allergan Inc. (AGN): Today's Featured Health Care Loser - TheStreet.com
- Allergan Inc. (AGN): Today's Featured Drugs Winner - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
RDA Microelectronics Announces Fourth Quarter and Full Year 2011 Financial Results -
Forum Subsea Technologies Wins Agreement With DOF Subsea for the Supply of Six Perry(TM) XLX ROV Systems -
StreamWIDE Enables Carriers to Run Value-Added Telephony Services on Amazon Web Services -
Forum Subsea Technologies Announces the Appointment of Two Senior Management Positions -
Citi California Pulse® Survey Finds Nearly Half of Californians Believe 2012 will be Better than 2011 -
Daimler Excels in Anniversary Year 2011: Group EBIT From Ongoing Business up by 24% to Record Level of Euro 9 Billion -
Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium -
UMC Reports Sales for January 2012










